Stockreport

GlycoMimetics Can Become A Game Changer In Blood Cancers [Seeking Alpha]

GlycoMimetics, Inc.  (GLYC) 
Last glycomimetics, inc. earnings: 5/1 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.glycomimetics.com/investor-relations
PDF AML is a disease with a poor prognosis, especially for elderly patients, and there is a need for better treatment options. Uproleselan, a glycomimetic drug, aims to a [Read more]